Eli Lilly LLY
First Signal's file · in 1 issue · All companies
Zepbound and Mounjaro
Every time it made the issue
We cover a company only when it moves enough to matter. Each row is one of those days, what we made of it, and how the stock did over the next 5 and 20 trading days, next to the S&P 500.
| Date | Where | Move | Our read | 5 days later | 20 days later |
|---|---|---|---|---|---|
| Thu, Oct 29, 2026 | Earnings | +6.6% | Earned $7.48 a share against $6.26 expected, on $24.4 billion of revenue against $22.61 billion, via CNBC. | to come | to come |
Its biggest days of the past ten years
| Best days | Move |
|---|---|
| Tue, Jun 16, 2020 | +15.7% |
| Tue, Aug 8, 2023 | +14.9% |
| Thu, Apr 17, 2025 | +14.3% |
| Worst days | Move |
|---|---|
| Thu, Aug 7, 2025 | −14.1% |
| Thu, May 1, 2025 | −11.7% |
| Wed, Nov 23, 2016 | −10.5% |
How it took its last 8 reports
The stock's move in the first session after each quarterly report. Next report: not yet announced.
| Results filed | Next session |
|---|---|
| Thu, Oct 29, 2026 | +6.6% |
| Wed, Aug 5, 2026 | +4.9% |
| Thu, Apr 30, 2026 | +9.8% |
| Wed, Feb 4, 2026 | +10.3% |
| Thu, Oct 30, 2025 | +3.8% |
| Thu, Aug 7, 2025 | −14.1% |
| Thu, May 1, 2025 | −11.7% |
| Thu, Feb 6, 2025 | +3.3% |
Moves are daily closing prices. Past moves don't predict future ones.